top of page
  • Actively engage with stakeholders, including patients, healthcare providers, regulators, scientific experts, technology providers and policy makers to understand and address their concerns surrounding patient centric sampling and analysis.

  • Act as a platform for collaborative activities associated with the development and implementation of patient centric sampling and analysis technologies for the provision of high quality information for decision making by stakeholders.

  • Act as a focal point for enquiries from stakeholders on patient centric sampling and related technologies.

  • Provide a framework for maintaining the highest standards of ethics, data integrity, scientific quality, compliance and transparency in the interest group’s activities.

  • Is free to join and is open to all that are interested in furthering its remit and no bias is shown to any particular organization or technology.


  • Company proprietary intellectual property will not be shared, unless publicly available.

  • Any promotional activities associated with the marketing and pricing of patient centric blood sampling and analysis technologies by the interest group members is outside the scope of this interest group.

bottom of page